Last reviewed · How we verify

NCT06279520

Driving Ability Evaluation System to Improve the Conditional Driving License System: Safety and Feasibility Study.

Status unknown NA Last updated 28 February 2024
What this trial tests

NA trial testing VR Driving Simulator in Automobile Driving in 100 participants. Status unknown.

Timeline
19 February 2024
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment100
Start date19 February 2024
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 65, any sex, with Automobile Driving. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities in healthy adults. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function and cognitive function of healthy drivers. to identify the correlation between their outcomes and the VR driving simulator's result

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of VR Driving Simulator

Trials testing the same drug.

Other recruiting trials for Automobile Driving

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06279520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing